← Leaderboards
Bahareh Behrouz
Michigan State University
$926,178
Attributed
$1,275,790
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $470.5K · FY2008–24$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,275,790 · 4
By mechanism
R43$1,250,709 · 3
F31$25,081 · 1
Top collaborators
- Michael Henderson2 shared
Most similar at Michigan State University
Same institution · by research overlap
- Nicholas M Kanaan$11,893,156
- John L Goudreau$3,178,275
- Lena Cecilia Brundin$4,983,208
- Rebecca Lynn Mueller$58,606
- Matthew John Benskey$666,125
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoBiological SciencesAffectPharmacologyPropertyToxic EffectCellsKnock-DownMotorPathway InteractionsFutureAnimal ModelSmall MoleculeTissuesLeadBiologyIn VitroPositioning AttributeBackMitochondriaMultidisciplinaryParkinson DiseaseAntimycinGenetic
Grant awards (5)
In vivo Evaluation of USP30 Inhibitors in Models Relevant to Parkinson's Disease$228,711
R43 · FY2024 · NS · contact PI
In vivo Evaluation of USP30 Inhibitors in Models Relevant to Parkinson's Disease$470,514
R43 · FY2023 · NS · contact PI
Evaluation of USP30 small molecule inhibitors in models relevant to Cardiac Aging$299,497
R43 · FY2022 · AG · contact PI
Discovery and Development of USP30 inhibitors as Disease-Modifying Therapy for Parkinson's disease.$251,987
R43 · FY2020 · NS · contact PI
Parkin and differential susceptibility of dopamine neurons in Parkinson's disease$25,081
F31 · FY2008 · NS · contact PI